Ifg Advisory, LLC Abbott Laboratories Transaction History

Ifg Advisory, LLC

$1.54 Billion
Q3 2024

A detailed history of Ifg Advisory, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ifg Advisory, LLC holds 31,992 shares of ABT stock, worth $3.65 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

31,992

Previous 30,164 6.06%

Holding current value

$3.65 Million

Previous $3.13 Million 16.37%

% of portfolio

0.24%

Previous 0.2%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$100.07 - $118.13 $182,927 - $215,941	1,828 Added 6.06%	31,992 $3.65 Million
Q2 2024 Jul 30, 2024	BUY	$100.73 - $112.44 $275,496 - $307,523	2,735 Added 9.97%	30,164 $3.13 Million
Q1 2024 May 06, 2024	SELL	$109.52 - $120.96 $481,778 - $532,103	-4,399 Reduced 13.82%	27,429 $3.12 Million
Q4 2023 Jan 17, 2024	BUY	$90.19 - $110.4 $97,585 - $119,452	1,082 Added 3.52%	31,828 $3.5 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $93,332 - $111,983	977 Added 3.28%	30,746 $2.98 Million
Q2 2023 Jul 21, 2023	BUY	$100.78 - $112.29 $358,676 - $399,640	3,559 Added 13.58%	29,769 $3.25 Million
Q1 2023 Apr 26, 2023	BUY	$96.86 - $114.01 $150,036 - $176,601	1,549 Added 6.28%	26,210 $2.65 Million
Q4 2022 Jan 31, 2023	BUY	$95.06 - $111.52 $31,464 - $36,913	331 Added 1.36%	24,661 $2.71 Million
Q3 2022 Oct 28, 2022	BUY	$96.76 - $112.03 $179,780 - $208,151	1,858 Added 8.27%	24,330 $2.35 Million
Q2 2022 Aug 04, 2022	BUY	$102.07 - $123.37 $1.34 Million - $1.62 Million	13,120 Added 140.29%	22,472 $2.44 Million
Q1 2022 May 04, 2022	SELL	$114.02 - $139.04 $53,931 - $65,765	-473 Reduced 4.81%	9,352 $1.11 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $41,706 - $51,067	361 Added 3.81%	9,825 $1.38 Million
Q3 2021 Oct 12, 2021	BUY	$116.66 - $129.06 $15,749 - $17,423	135 Added 1.45%	9,464 $1.12 Million
Q2 2021 Jul 21, 2021	SELL	$105.79 - $124.53 $118,167 - $139,100	-1,117 Reduced 10.69%	9,329 $1.08 Million
Q1 2021 Apr 19, 2021	SELL	$108.84 - $128.23 $1,632 - $1,923	-15 Reduced 0.14%	10,446 $1.25 Million
Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $3.13 Million - $3.41 Million	-29,840 Reduced 74.04%	10,461 $1.15 Million
Q3 2020 Nov 02, 2020	BUY	$91.64 - $111.29 $2.72 Million - $3.3 Million	29,633 Added 277.77%	40,301 $1.9 Million
Q2 2020 Aug 10, 2020	BUY	$76.57 - $98.0 $30,781 - $39,396	402 Added 3.92%	10,668 $975,000
Q1 2020 May 11, 2020	SELL	$62.82 - $91.86 $76,891 - $112,436	-1,224 Reduced 10.65%	10,266 $810,000
Q4 2019 Feb 07, 2020	BUY	$78.51 - $87.4 $7,301 - $8,128	93 Added 0.82%	11,490 $998,000
Q3 2019 Nov 06, 2019	SELL	$81.84 - $88.74 $34,700 - $37,625	-424 Reduced 3.59%	11,397 $953,000
Q2 2019 Aug 06, 2019	SELL	$72.88 - $85.0 $478,967 - $558,620	-6,572 Reduced 35.73%	11,821 $994,000
Q1 2019 May 08, 2019	SELL	$66.22 - $80.06 $395,465 - $478,118	-5,972 Reduced 24.51%	18,393 $1.47 Million
Q4 2018 Feb 07, 2019	SELL	$65.56 - $74.27 $360,186 - $408,039	-5,494 Reduced 18.4%	24,365 $1.76 Million
Q3 2018 Nov 05, 2018	BUY	$60.81 - $73.36 $24,810 - $29,930	408 Added 1.39%	29,859 $2.19 Million
Q2 2018 Aug 02, 2018	SELL	$57.57 - $63.54 $926,934 - $1.02 Million	-16,101 Reduced 35.35%	29,451 $1.8 Million
Q1 2018 Apr 26, 2018	SELL	$56.27 - $63.62 $16,599 - $18,767	-295 Reduced 0.64%	45,552 $0
Q4 2017 Feb 01, 2018	BUY	$53.68 - $57.47 $2.37 Million - $2.54 Million	44,170 Added 2633.87%	45,847 $2.62 Million
Q4 2017 Jan 29, 2018	BUY	$53.68 - $57.47 $90,021 - $96,377	1,677	1,677 $2.82 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ifg Advisory, LLC with notifications on news.

Account